Navigate Fool.com
Will OMPI beat
the market?
Community Rating: 3 Stars: Appealing

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.83

How do you think OMPI
will perform against the market?

Top OMPI Bull/Bear Pitches


BSHumphreyII (< 20)
Submitted January 1, 2009

Obagi has had an earnings dip this year, but it's hard to hold that against them in this economy. Before that, they've had very strong earnings growth and fantastic return on equity and invested capi … More

0 Replies Reply Report this Post

chk999 (< 20)
Submitted July 23, 2007

Purely a momentum play. This is very down <br /><br />on a day the market is climbing.

0 Replies Reply Report this Post

News & Commentary

The Great Acquirer Strikes Again

But is this proposed merger of equals a mistake?

Canadian Market Climbs Nearly 130 Points, Holding Near Its Best Levels Of The Day

Valeant Receives Antitrust Clearance for Obagi Purchase

Transaction still requires approval of Ukranian antimonopoly regulators.

Mario Gabelli - Active Trading LUFK, SUP, OMPI

Mario Gabelli - Active Trading LUFK, SUP, OMPI

This Bidding War Was a Bidding Skirmish

The bidding war for Obagi Medical Products is over, and everyone's a winner.

Merz Drops Out of Bidding for Obagi Medical

Valeant wins.


Merz Pharma Withdraws Offer for Obagi Medical After Valeant's Sweetened Bid

3 Humongous Health-Care Stocks This Week

These health care stocks made big gains to open the new month.

Possible Synergies in This Buyout

See More OMPI News...





Obagi Medical Products, Inc. (OMPI) Description

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems. Website: http://www.obagi.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks